Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment

Inclusion Criteria: * Subject with normal hepatic function or hepatic impairment (mild, moderate or severe) * Body mass index (BMI) 18.5-40.0 kg/m\^2 (both inclusive) Exclusion Criteria: * Female who is pregnant, breast-feeding or intends to become pregnant or is of child-bearing potential and not using adequate contraceptive methods * History of Crohn's disease, ulcerative colitis, or other inflammatory bowel disease * Uncontrolled hypertension (defined as systolic blood pressure above or equal to 180 mmHg and/or diastolic blood pressure above or equal to 100 mmHg) * Any donation of blood or plasma in excess of 400 mL within the 3 months preceding screening * History of significant drug abuse, or a positive drug test at the screening visit (Visit 2)